Who invested in Solve Therapeutics?
Solve Therapeutics's investors include General Atlantic and B Capital.
United States · Series A startup
2 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 12 months ago
Funding summaryUpdated 26 Oct 2026
$170Mraised across 2 rounds since 2024, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $48M sold, first sale Nov 2025
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Solve Therapeutics's investors include General Atlantic and B Capital.
Solve Therapeutics has raised $170M across 2 rounds since 2024.
Solve Therapeutics's most recent round was a Series A of $120M in Nov 2025.
Its most recent round, $120M in Nov 2025, is also its largest on record.
Solve Therapeutics's first round on record, in Dec 2024, was backed by General Atlantic.
Solve Therapeutics's latest named round is a Series A, in Nov 2025.
Solve Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.